Results

Total Results: 1,112 records

Showing results for "phase".

1021. Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/uterine-fibroids-2010/research
      March 10, 2011 - Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease Research Report March 10, 2011 Download Main Document PDF 990.1 KB This report is available in PDF (990 kB) only. Peopleusing assistive technology may not be able to fully access information in this file. …

1022. Pediatric Quality Measures Program 3.0: An Evidence Map of Measures for Vision, Hearing, and Developmental Screening and Followup (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/pqmp-protocol.pdf
      April 01, 2014 - Research and Quality (AHRQ) and the Centers for Medicare & Medicaid Services (CMS).2 In the first phase … portfolio of evidence- based pediatric quality measures, which were endorsed nationally.2, 3 In the second phase

1023. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/cesarean-birth-2010_research-protocol.pdf
      January 01, 2010 - exclusion criteria we selected based on our understanding of the literature, the topic-refinement phase … at Source: www.effectivehealthcare.ahrq.gov Published Online: May 6, 2011 the abstract phase

1024. Project Title: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques, a Technical Brief (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
      August 23, 2010 - Discussions with Key Informants A representative panel of Key Informants, referred to in this phase

1025. Autism Spectrum Disorder — An Update | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/autism-update/research-protocol
      September 20, 2013 - Question 3 Are there any identifiable changes early in the treatment phase that predict treatment outcomes … Question 4 What is the evidence that effects measured at the end of the treatment phase predict long-term … investigative team will also scan the reference lists of articles that are included after the full-text review phase

1026. Models of Survivorship Care: Technical Brief | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/cancer-survivor-care-transition/research-protocol
      March 29, 2013 - We will retrieve and review the full text of all articles included during the title/abstract review phase … on the health and life of a person with a history of cancer beyond the acute diagnosis and treatment phase

1027. AHRQ Slide Template 2009 (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
      March 01, 2010 - growth hormone (rhGH), we needed to devise key questions that, when subsequently answered in the next phase … This completes the topic refinement project and sets the stage for the next phase, in which the key questions … Studies are evaluated in this phase to review methods and demographics, not results.

1028. Evidence Report on the (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
      November 01, 2010 - Abstracts from studies identified in the electronic literature searches, during the public comment phase … Similar to the abstract review process, reasons for exclusion of articles at the extraction phase will

1029. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
      July 06, 2015 - angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase … Full text articles for all citations progressed through the title/abstract review phase were assessed … angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase … angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase … ;METHODS: PARAMOUNT was a phase 2, randomised, parallel-group, double-blind multicentre trial in patients

1030. Breast-Abnormalities-Tests-Update Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_executive.pdf
      February 01, 2012 - Detection and prediction of breast cancer using couble phase Tc-99m MIBI scintimammography in comparison … Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization … Diagnostic performances of double-phase tc-99m MIBI scintimammography in patients with indeterminate

1031. Methods Guide for Medical Test Reviews Chapter 2 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
      July 01, 2012 - Methods Guide for Medical Test Reviews Chapter 2 2-1 Chapter 2 Developing the Topic and Structuring Systematic Reviews of Medical Tests: Utility of PICOTS, Analytic Frameworks, Decision Trees, and Other Frameworks David Samson, M.S., Blue Cross and Blue Shield Association Karen M. Schoelles M.D., S.…

1032. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
      April 01, 2011 - Takeda has completed a phase 1, randomized, open-label, 2 period, crossover study to evaluate the effect … release (MR) - The objective of the study was to assess the safety of dexlansoprazole MR from the phase … Pediatric patients - Dexlansoprazole is not FDA approved for use in patients less than 18 years of age.1A phase … dexlansoprazole in adolescents 12-17 years of age with symptomatic GERD has been completed.8 A second phase

1033. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
      March 16, 2017 - not all effects are likely to become evident in all patients within the one-to-two month treatment phase … own “across study” subgroup analyses using study-level data on our variables of interest (e.g., phase … We are happy our interpretations were correct for the controlled phase. … Thank you for sharing the results from the open label phase, although this does not meet our inclusion

1034. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
      March 16, 2017 - not all effects are likely to become evident in all patients within the one-to-two month treatment phase … own “across study” subgroup analyses using study-level data on our variables of interest (e.g., phase … We are happy our interpretations were correct for the controlled phase. … Thank you for sharing the results from the open label phase, although this does not meet our inclusion

1035. Juvenile-Arthritis-Dmards Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
      March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections

1036. Juvenile-Arthritis-Dmards Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
      March 14, 2013 - psoriatic arthritis: results of a six- month, multicenter, randomized, double- blind, placebo-controlled, phase … A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of … AEs during double blind phase included 159 events w/ tocilizumab vs 38 w/ placebo including 60 infections

1037. McCormack-notes-151008 copy - Teresa (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/mccormack-presentation.pdf
      November 12, 2015 - McCormack-notes-151008 copy - Teresa My talk today is about engaging patients with  low health  literacy. 1 Health literacy is a key factor in securing access to healthcare services. So in my talk today, I’ll talk a little bit about health literacy and what it is, how we measure health literacy and the sta…

1038. Schwitzer_ECCS2012 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
      July 23, 2012 - Schwitzer_ECCS2012 Slide 1: Addressing  Tensions  When Popular Media and Evidence-­‐Based Care Collide Gary  Schwitzer Publisher,  HealthNewsReview.org Slide 2: Infoxication We are drowning people who are thirsty for just a sip of balanced infor…

1039. Disposition of Comments Report for Comparative Effectiveness Review No. 137 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-update_disposition-comments.pdf
      August 06, 2014 - Behavioral Health and Wellness) General Are there any identifiable changes early in the treatment phase … Health and Wellness) General What is the evidence that effects measured at the end of the treatment phase

1040. #06 Developmental Delays ADHD, and Autism (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
      January 01, 2012 - inclusion are those interventions expected to be within 0 to 4 years of potential diffusion (e.g., in phase … III trials for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … Results The table below lists the six topics for which (1) preliminary phase III data were available … Currently interventions such as this humanoid robotic doll are in an early phase of development and